As the United States marks the tenth anniversary of the establishment of a biosimilars pathway, many experts express frustration that the US lags behind
Europe. A new white paper from Matrix Global Advisors carefully examines the US and European biosimilars markets and finds that the comparison between the markets is nuanced.
Matrix Global Advisors (MGA) today released a new report, “Shared Savings Demonstration for Biosimilars in Medicare: An Opportunity to Promote Biologic Drug Competition,” by MGA founder and CEO Alex Brill. The report identifies a unique opportunity in Medicare Part B to boost biosimilar utilization through the establishment of a shared savings demonstration model administered by the Centers for Medicare & Medicaid Services Innovation Center.
DetailsThe COVID-19 outbreak may be as severe as the 1918 influenza pandemic that killed an estimated 675,000 people in the U.S., according to a report by consulting firm Matrix Global Advisors.
Details“We want the program to work and I think that sadly what we’re seeing is that the program is working quite well. And I say sadly because we are seeing tens of millions of people process through that system and we’re going to continue to see that I think for the next few weeks as the backlogs in certain states get worked through…”
Details“‘That could help accelerate the rebound if we can just kind of mothball the economy and then turn back on the same economy with the same manager-employee relationship,” said Alex Brill, a resident fellow at the right-leaning American Enterprise Institute.”
DetailsA new report released today by Matrix Global Advisors (MGA) finds that COVID-19 is likely as severe as the 1918 pandemic, the worst pandemic in the twentieth century. MGA evaluated COVID-19 data using the Centers for Disease Control and Prevention’s Pandemic Severity Assessment Framework (PSAF) and found that the current pandemic’s clinical severity (how sick the virus makes people) and transmissibility (how contagious the virus is) are the highest measurable by that tool.
DetailsAlex Brill was one of the panelists discussing his “commitment to expand biosimilar use in the United States and how physicians and government officials are looking to help.
DetailsRecent news about e-cigarette misuse has fueled both public misperception and policy responses that are likely to have unintended consequences. As the US vaping market continues to evolve, policymakers face the tricky challenge of safeguarding the potential for positive public health outcomes from e-cigarettes, which offer a lower-risk alternative to traditional cigarettes, while ensuring reasonable protections against youth use.
Details“The main conclusion of Brill’s report is that Teva makes a significant contribution to the economies of the countries where it operates, via both direct and indirect employment.”
DetailsBased on MGA’s independent analysis, the Teva Global Economic Impact Report estimates Teva’s economic impact in 19 of the 60 countries in which Teva operates.
Details
